Related Experiment Video
Updated: Jan 15, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Effectiveness of metabolic management centers online tools in patients with type 2 diabetes
Miao Xu1, Jialin Li1, Ying Peng2,3
1Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Objectives:
To assess the value of National Metabolic Management Centers (MMC) specialized online tools, for the maintenance of metabolic control among patients with type 2 diabetes (T2DM).
Patients:
This retrospective study enrolled T2DM patients from 10 MMCs (June 2017-April 2021) and divided into non- and application of online tools (non-AOT and AOT) groups.
Measurements:
Propensity score matching (PSM) was used to balance the characteristics of patients between groups. The effect of online tools was evaluated by the change in HbA1c, with additional stratified analyses in subgroups.
Results:
After PSM, 12528 patients with T2DM were followed for a median of 15.88 (7.10, 24.27) months, the AOT group demonstrated better control of HbA1c (-0.90 [-2.60, 0.00] % vs. -0.70 [-2.20, 0.10] %, p < 0.0001), and a greater reduction in body mass index (-0.34 ± 1.68 kg/m2 vs. -0.13 ± 1.55 kg/m2, p < 0.0001) and Visceral fat area (VFA) (-5.33 ± 30.95 cm2 vs. -3.97 ± 26.11 cm2, p = 0.009), compared to the non-AOT group, and the high-frequency AOT group achieved a more significant HbA1c reduction than the low-frequency AOT group (-1.50 [-3.60, -0.30] % vs. -0.80 [-2.38, 0.10] %, p < 0.0001) and a greater reduction in VFA (-7.07 ± 30.32 cm2 vs. -4.90 ± 31.10 cm2, p = 0.010) after adjustment. Stratification analyses revealed greater HbA1c reductions in those with younger age, lower education level or poor HbA1c control at baseline.
Conclusions:
MMC online tools significantly improve metabolic outcomes, particularly for T2DM patients with younger age, lower education levels or poor baseline HbA1c control. They offer a scalable and effective model for out-of-hospital diabetes care.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Therapeutic Drug Monitoring: Affecting Factors
Atherosclerosis III: Management

